Skip to main content
. 2018 Nov 21;8(4):114. doi: 10.3390/bios8040114

Table 1.

Examples of assay components and immobilisation strategies for cTnI detection.

Detection Approach Biorecognition Element Immobilisation Strategy LOD
Optical [85] Monoclonal Antibody Ab/EDC/NHS/Dextran SAM/Tboc/Si Wafer 5 ng/L
Photoelectrochemical [86] Antibody * Ab/EDC/NHS/TGA/CdS/N,S-GQDs/Zn2SnO4/ITO 0.3 ng/L
Luminescence [87] Monoclonal Antibody Ab/Ru/EDC/NHS/PAMAM/AuNPs/Nafion/GCE 12 pg/L
Electrochemical [61] MIPs MIPs/MWCNT/GS/GCE 0.8 ng/L
Luminescence [88] Aptamer QD/EDC/NHS/L1/Aptamer/L2/DTT/AuNP 7.2 μg/L
Luminescence [89] Antibody* Biotin-Ab/Streptavidin/Magnetic-NPs/GCP 0.2 ng/L

* Type of antibody has not been disclosed. Tboc—10-N-Boc-Amino-dec-1-ene; Si Wafer—Silicon wafer; TGA—Thioglycolic acid; CdS—Cadimium sulphur; N,S-GQDs—Graphene quantum dots doped with nitrogen and sulfu; Zn2SnO4—Zinc stannate; ITO—Indium tine oxide; Ru—Tris (4,4_-dicarboxylicacid-2,2_-bipyridyl) ruthe-nium(II) dichloride; GCE—Glassy Carbon Electrode; GS—Graphene Nanoplatlets; QD—Quantum Dot; L1—Oligonucleotide linker (GGTGGTGGT- C6 Amine); L2—Oligonucleotide linker (Thiol-GAAGAAGAA); DTT—Dithiothreitol; GCP—Glassy carbon plate.